VRTX fundamentals
An in-depth look to Vertex Pharmaceuticals Incorporated operating, investing, and financing activities
VRTX free cash flow for Q2 24 is -3.82 B USD. For 2023, VRTX free cash flow was 3.34 B USD and operating cash flow was 3.54 B USD.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM